We’re now inviting expressions of interest from practices keen to welcome a new graduate nurse to their team in 2026. With the Te Whatu Ora ACE recruitment process opening on 6 August 2025 (closing date TBC), this is your chance to indicate your interest early. We’ll work alongside your regional Te Whatu Ora Nurse Entry to Practice (NETP) coordinator to support the recruitment process and help ensure a smooth pathway into practice.

The Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications. The aims are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification. For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway for guidance.

Pathlab has had an equipment failure, compounded by a delayed replacement device delivery, impacting the following tests: Anti-TPO antibodies, CMV serology, EBV serology, Hepatitis B serology, Hepatitis A serology, Hepatitis C antibody, HIV serology, Rubella IgG, Syphilis screen and Toxoplasma serology. Please keep sending in the tests but expect an additional 1-2 weeks delay in reporting.

Te Whatu Ora has made a number of changes to immunisation funding within the PHOSA as part of the 1 July 25 annual uplift contract variation.

Introducing Carey Campbell, Clinical Director, McCrae Tech, who will be speaking at our Pinnacle nursing conference on Saturday 11 October at our Kirikiriroa Hamilton office. Read about Carey in her bio.

Funding is now available for primary care, community, and rural health providers who are committed to supporting graduate registered nurses (RN) as they transition into practice. To be eligible for placement funding, employers must employ a graduate RN, provide preceptorship and clinical support, and hire the graduate RN for a minimum of 0.6 FTE for a period of 12 months or more.